Advanced search
Publication Cover
Acta Oncologica Volume 60, 2021 - Issue 1
Journal homepage
1,762
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor: Current Challenges; COVID-19

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study

Alexander Hölleina Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
,
Peter Bojkoa Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
,
Sebastian Schulza Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
,
Julia Neitza Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
,
Oliver Stötzerb Medical Center for Hematology and Oncology, Munich, Germany
,
Rudolf Pihuschc Medical Care Center Rosenheim, Rosenheim, Germany
,
Fariborz Abedinpourd Departmrnt of Hematology and Oncology, Josephinum Hospital, Munich, Germany
,
Burkhard Schmidte Practice of Hematology and Oncology Pasing, Munich, Germany
&
Marcus Hentricha Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Ludwig-Maximilians-University of Munich, Munich, GermanyCorrespondence[email protected]
 show all
Pages 24-27 | Received 29 Sep 2020, Accepted 08 Dec 2020, Published online: 05 Jan 2021

References

  • Giesen N, Sprute R, Rüthrich M, et al. Evidence-based management of COVID-19 in cancer patients - guideline by the infectious diseases working party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Eur J Cancer. 2020;140:86–104.
  • Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):893–903.
  • Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935–941.
  • Brar G, Pinheiro LC, Shusterman M, et al. COVID-19 severity and outcomes in patients with cancer: a matched cohort study. J Clin Oncol. 2020;38(33):3914–3924.
  • El-Sharkawi D, Iyengar S. Haematological cancers and the risk of severe COVID-19: exploration and critical evaluation of the evidence to date. Br J Haematol. 2020;190(3):336–345.
  • Yu J, Ouyang W, Chua MLK, et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108–1111.
  • He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–1645.
  • Ferrara F, Zappasodi P, Roncoroni E, et al. Impact of Covid-19 on the treatment of acute myeloid leukemia. Leukemia. 2020;34(8):2254–2256.
  • Carroll E, Lewis A. Catastrophic intracranial hemorrhage in two critically ill patients with COVID-19. Neurocrit Care. 2020;26:1–5.
  • Ghani MU, Kumar M, Ghani U, et al. Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients. J Neurovirol. 2020;26(4):602–604.
  • Li W, Wang D, Guo J, et al. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020;34(7):1799–1804.
  • Abruzzese E, Luciano L, D’Agostino F, et al. SARS-CoV-2 (COVID-19) and chronic myeloid leukemia (CML): a case report and review of ABL kinase involvement in viral infection. Mediterr J Hematol Infect Dis. 2020;12(1):e2020031.
  • Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918.
  • Martin-Moro F, Marquet J, Piris M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020;190(1):e16–e20.
  • Fattizzo B, Giannotta JA, Sciumè M, et al. Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality. Leukemia. 2020;34(7):1957–1960.
  • Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective cohort study. Lancet Oncol. 2020;21(7):904–913.
  • Aries JA, Davies JK, Auer RL, et al. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients. Br J Haematol. 2020;190(2):e64–e67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.